*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct - as a primary diagnosis code | C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.1 | |
| Readmission Rate (%) | 27.35 | |
| Unplanned Readmission Rate (%) | 17.97 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 436: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 406: PANCREAS, LIVER AND SHUNT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 437: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 407: PANCREAS, LIVER AND SHUNT PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 40,116 | ||||
| Total Hospitalizations with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 9,326 | ||||
| DRG Share of Total Hospitalizations | 0.12 | ||||
| % of Total ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct in DRG | 36.95 | ||||
| Avg LOS at DRG | 6.14 | ||||
| Avg LOS with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 6.32 | ||||
| Readmission Rate at DRG | 26.88 | ||||
| Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 23.74 | ||||
| Unplanned Readmission Rate at DRG | 18.3 | ||||
| Unplanned Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 18.65 | ||||
| Total Medicare payments at DRG | $472,915,537 | ||||
| Total Medicare payments with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $110,049,375 | ||||
| Total Medicare payment per Day at DRG | $1,921 | ||||
| Total Medicare payment per Day with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $1,867 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,789 | ||||
| Total Medicare payment per Hospitalization with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $11,800 | ||||
| Total Medicare Charges at DRG | $2,356,079,688 | ||||
| Total Medicare Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $528,357,389 | ||||
| Avg Charges at DRG | $58,732 | ||||
| Avg Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $56,654 | ||||
| Mortality Rate at DRG | 10.79 | ||||
| Mortality Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 16.38 | ||||
| SNF Discharge Rate at DRG | 10.16 | ||||
| SNF Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 10.17 | ||||
| Home Discharge Rate at DRG | 35.89 | ||||
| Home Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 25.44 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 405: PANCREAS, LIVER AND SHUNT PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 421: HEPATOBILIARY DIAGNOSTIC PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 420: HEPATOBILIARY DIAGNOSTIC PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 408: BILIARY TRACT PROCEDURE EXCEPT ONLY CHOLECYSTECTOMY WITH OR WITHOUT C.D.E. WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 988: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 12,032 | ||||
| Total Hospitalizations with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 621 | ||||
| DRG Share of Total Hospitalizations | 0.04 | ||||
| % of Total ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct in DRG | 2.46 | ||||
| Avg LOS at DRG | 12.83 | ||||
| Avg LOS with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 11.12 | ||||
| Readmission Rate at DRG | 32.87 | ||||
| Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 25.66 | ||||
| Unplanned Readmission Rate at DRG | 17.21 | ||||
| Unplanned Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 11.42 | ||||
| Total Medicare payments at DRG | $494,323,756 | ||||
| Total Medicare payments with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $24,705,061 | ||||
| Total Medicare payment per Day at DRG | $3,203 | ||||
| Total Medicare payment per Day with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $3,576 | ||||
| Total Medicare payment per Hospitalization at DRG | $41,084 | ||||
| Total Medicare payment per Hospitalization with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $39,783 | ||||
| Total Medicare Charges at DRG | $2,312,237,801 | ||||
| Total Medicare Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $115,577,794 | ||||
| Avg Charges at DRG | $192,174 | ||||
| Avg Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $186,116 | ||||
| Mortality Rate at DRG | 6.86 | ||||
| Mortality Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 6.44 | ||||
| SNF Discharge Rate at DRG | 17.46 | ||||
| SNF Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 14.17 | ||||
| Home Discharge Rate at DRG | 36.29 | ||||
| Home Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 43.32 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 423: OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 415: CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE WITHOUT C.D.E. WITH COMPLICATION OR COMORBIDITY (CC) | DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 3,125 | ||||
| Total Hospitalizations with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 164 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct in DRG | 0.65 | ||||
| Avg LOS at DRG | 12.1 | ||||
| Avg LOS with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 9.84 | ||||
| Readmission Rate at DRG | 34.89 | ||||
| Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 38.76 | ||||
| Unplanned Readmission Rate at DRG | 23.07 | ||||
| Unplanned Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 27.91 | ||||
| Total Medicare payments at DRG | $99,649,034 | ||||
| Total Medicare payments with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $4,719,315 | ||||
| Total Medicare payment per Day at DRG | $2,636 | ||||
| Total Medicare payment per Day with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $2,926 | ||||
| Total Medicare payment per Hospitalization at DRG | $31,888 | ||||
| Total Medicare payment per Hospitalization with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $28,776 | ||||
| Total Medicare Charges at DRG | $437,724,723 | ||||
| Total Medicare Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $19,590,830 | ||||
| Avg Charges at DRG | $140,072 | ||||
| Avg Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $119,456 | ||||
| Mortality Rate at DRG | 8.93 | ||||
| Mortality Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 17.07 | ||||
| SNF Discharge Rate at DRG | 17.95 | ||||
| SNF Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 14.02 | ||||
| Home Discharge Rate at DRG | 35.01 | ||||
| Home Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 24.39 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 422: HEPATOBILIARY DIAGNOSTIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 424: OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 409: BILIARY TRACT PROCEDURE EXCEPT ONLY CHOLECYSTECTOMY WITH OR WITHOUT C.D.E. WITH COMPLICATION OR COMORBIDITY (CC) | DRG 989: NON-EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 418: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 925 | ||||
| Total Hospitalizations with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 67 | ||||
| DRG Share of Total Hospitalizations | 0.0 | ||||
| % of Total ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct in DRG | 0.27 | ||||
| Avg LOS at DRG | 3.34 | ||||
| Avg LOS with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 3.04 | ||||
| Readmission Rate at DRG | 17.55 | ||||
| Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | NA | ||||
| Unplanned Readmission Rate at DRG | 11.55 | ||||
| Unplanned Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | NA | ||||
| Total Medicare payments at DRG | $7,900,832 | ||||
| Total Medicare payments with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $515,591 | ||||
| Total Medicare payment per Day at DRG | $2,558 | ||||
| Total Medicare payment per Day with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $2,527 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,541 | ||||
| Total Medicare payment per Hospitalization with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $7,695 | ||||
| Total Medicare Charges at DRG | $45,682,355 | ||||
| Total Medicare Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $3,697,196 | ||||
| Avg Charges at DRG | $49,386 | ||||
| Avg Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $55,182 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | NA | ||||
| SNF Discharge Rate at DRG | 4.43 | ||||
| SNF Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | NA | ||||
| Home Discharge Rate at DRG | 78.05 | ||||
| Home Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 89.55 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 464 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 327 |
| MASSACHUSETTS GENERAL HOSPITAL | 55 FRUIT ST | BOSTON | MA | 02114 | 146 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MICHAEL I D'ANGELICA | 1275 YORK AVE | NEW YORK | NY | 10021 | 48 |
| Dr. DAVID A GELLER | 3459 5TH AVE | PITTSBURGH | PA | 15213 | 41 |
| Dr. WILLIAM R JARNAGIN | 1275 YORK AVE | NEW YORK | NY | 10021 | 40 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MICHAEL I D'ANGELICA | 1275 YORK AVE | NEW YORK | NY | 10021 | 50 |
| Dr. WILLIAM R JARNAGIN | 1275 YORK AVE | NEW YORK | NY | 10021 | 42 |
| Dr. DAVID A GELLER | 3459 5TH AVE | PITTSBURGH | PA | 15213 | 38 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 436: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 31,353 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct in DRG | 9.19 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 6.19 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 23.78 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 17.95 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $388,799,672 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $2,004 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $12,401 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $2,021,537,356 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $64,477 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 26.61 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 12.24 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 16.79 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 181: RESPIRATORY NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 32,646 | ||||
| Total Hospitalizations with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 9,154 | ||||
| DRG Share of Total Hospitalizations | 0.1 | ||||
| % of Total ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct in DRG | 2.68 | ||||
| Avg LOS at DRG | 7.59 | ||||
| Avg LOS with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 7.46 | ||||
| Readmission Rate at DRG | 28.12 | ||||
| Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 25.58 | ||||
| Unplanned Readmission Rate at DRG | 19.5 | ||||
| Unplanned Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 19.52 | ||||
| Total Medicare payments at DRG | $468,044,879 | ||||
| Total Medicare payments with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $131,537,304 | ||||
| Total Medicare payment per Day at DRG | $1,889 | ||||
| Total Medicare payment per Day with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $1,925 | ||||
| Total Medicare payment per Hospitalization at DRG | $14,337 | ||||
| Total Medicare payment per Hospitalization with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $14,369 | ||||
| Total Medicare Charges at DRG | $2,155,025,187 | ||||
| Total Medicare Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $588,458,696 | ||||
| Avg Charges at DRG | $66,012 | ||||
| Avg Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $64,284 | ||||
| Mortality Rate at DRG | 11.79 | ||||
| Mortality Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 15.73 | ||||
| SNF Discharge Rate at DRG | 13.92 | ||||
| SNF Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 11.33 | ||||
| Home Discharge Rate at DRG | 26.98 | ||||
| Home Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 23.3 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 434,264 | ||||
| Total Hospitalizations with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 5,092 | ||||
| DRG Share of Total Hospitalizations | 1.32 | ||||
| % of Total ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct in DRG | 1.49 | ||||
| Avg LOS at DRG | 3.94 | ||||
| Avg LOS with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 4.3 | ||||
| Readmission Rate at DRG | 22.76 | ||||
| Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 27.57 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 20.97 | ||||
| Total Medicare payments at DRG | $2,472,138,198 | ||||
| Total Medicare payments with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $30,983,447 | ||||
| Total Medicare payment per Day at DRG | $1,444 | ||||
| Total Medicare payment per Day with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $1,416 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,693 | ||||
| Total Medicare payment per Hospitalization with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $6,085 | ||||
| Total Medicare Charges at DRG | $12,478,361,060 | ||||
| Total Medicare Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $166,992,491 | ||||
| Avg Charges at DRG | $28,735 | ||||
| Avg Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $32,795 | ||||
| Mortality Rate at DRG | 0.91 | ||||
| Mortality Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 5.46 | ||||
| SNF Discharge Rate at DRG | 22.02 | ||||
| SNF Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 12.1 | ||||
| Home Discharge Rate at DRG | 46.68 | ||||
| Home Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 39.63 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 106,782 | ||||
| Total Hospitalizations with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 4,265 | ||||
| DRG Share of Total Hospitalizations | 0.32 | ||||
| % of Total ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct in DRG | 1.25 | ||||
| Avg LOS at DRG | 13.16 | ||||
| Avg LOS with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 13.54 | ||||
| Readmission Rate at DRG | 30.28 | ||||
| Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 27.93 | ||||
| Unplanned Readmission Rate at DRG | 15.8 | ||||
| Unplanned Readmission Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 15.87 | ||||
| Total Medicare payments at DRG | $3,545,118,598 | ||||
| Total Medicare payments with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $141,167,993 | ||||
| Total Medicare payment per Day at DRG | $2,523 | ||||
| Total Medicare payment per Day with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $2,445 | ||||
| Total Medicare payment per Hospitalization at DRG | $33,200 | ||||
| Total Medicare payment per Hospitalization with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $33,099 | ||||
| Total Medicare Charges at DRG | $16,714,197,313 | ||||
| Total Medicare Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $669,586,559 | ||||
| Avg Charges at DRG | $156,526 | ||||
| Avg Charges with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | $156,996 | ||||
| Mortality Rate at DRG | 9.42 | ||||
| Mortality Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 12.94 | ||||
| SNF Discharge Rate at DRG | 28.14 | ||||
| SNF Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 23.33 | ||||
| Home Discharge Rate at DRG | 22.53 | ||||
| Home Discharge Rate with ICD C787 - Secondary malignant neoplasm of liver and intrahepatic bile duct | 16.48 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 3,776 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 2,613 |
| BRIGHAM AND WOMEN'S HOSPITAL | 75 FRANCIS ST | BOSTON | MA | 02115 | 1,414 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MARK J AULT | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048 | 109 |
| Dr. JOSEPH PATRICK ERINJERI | 560 1ST AVE | NEW YORK | NY | 10016 | 70 |
| Dr. RAMAKRISHNA BATTINI | 111 E 210TH ST | BRONX | NY | 10467 | 63 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. CHHAVI BANSAL KUMAR | 550 1ST AVE | NEW YORK | NY | 10016 | 205 |
| Dr. DOUGLAS JUNWOO KOO | 1275 YORK AVE | NEW YORK | NY | 10065 | 171 |
| Dr. SATINDERJIT S OBEROI | 902 N RIVERSIDE RD | SAINT JOSEPH | MO | 64507 | 154 |